Addex Therapeutics Stock Market Value
ADXN Stock | USD 8.15 0.62 8.23% |
Symbol | Addex |
Addex Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (21.86) | Revenue Per Share 1.2 | Quarterly Revenue Growth (0.82) | Return On Assets (0.62) | Return On Equity (1.26) |
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Addex Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Addex Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Addex Therapeutics.
11/10/2024 |
| 12/10/2024 |
If you would invest 0.00 in Addex Therapeutics on November 10, 2024 and sell it all today you would earn a total of 0.00 from holding Addex Therapeutics or generate 0.0% return on investment in Addex Therapeutics over 30 days. Addex Therapeutics is related to or competes with Innate Pharma, Aptorum Group, Dyadic International, Soligenix, Avenue Therapeutics, Kronos Bio, and Cyclerion Therapeutics. Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-mol... More
Addex Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Addex Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Addex Therapeutics upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.1) | |||
Maximum Drawdown | 29.35 | |||
Value At Risk | (7.40) | |||
Potential Upside | 9.74 |
Addex Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Addex Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Addex Therapeutics' standard deviation. In reality, there are many statistical measures that can use Addex Therapeutics historical prices to predict the future Addex Therapeutics' volatility.Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.24) | |||
Total Risk Alpha | (1.34) | |||
Treynor Ratio | 0.4018 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Addex Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Addex Therapeutics Backtested Returns
Addex Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0444, which signifies that the company had a -0.0444% return per unit of standard deviation over the last 3 months. Addex Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Addex Therapeutics' mean deviation of 3.73, and Risk Adjusted Performance of (0.04) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.93, which signifies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Addex Therapeutics are expected to decrease slowly. On the other hand, during market turmoil, Addex Therapeutics is expected to outperform it slightly. At this point, Addex Therapeutics has a negative expected return of -0.23%. Please make sure to confirm Addex Therapeutics' skewness, and the relationship between the total risk alpha and day median price , to decide if Addex Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.18 |
Very weak predictability
Addex Therapeutics has very weak predictability. Overlapping area represents the amount of predictability between Addex Therapeutics time series from 10th of November 2024 to 25th of November 2024 and 25th of November 2024 to 10th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Addex Therapeutics price movement. The serial correlation of 0.18 indicates that over 18.0% of current Addex Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.18 | |
Spearman Rank Test | 0.67 | |
Residual Average | 0.0 | |
Price Variance | 0.23 |
Addex Therapeutics lagged returns against current returns
Autocorrelation, which is Addex Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Addex Therapeutics' stock expected returns. We can calculate the autocorrelation of Addex Therapeutics returns to help us make a trade decision. For example, suppose you find that Addex Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Addex Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Addex Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Addex Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Addex Therapeutics stock over time.
Current vs Lagged Prices |
Timeline |
Addex Therapeutics Lagged Returns
When evaluating Addex Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Addex Therapeutics stock have on its future price. Addex Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Addex Therapeutics autocorrelation shows the relationship between Addex Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Addex Therapeutics.
Regressed Prices |
Timeline |
Pair Trading with Addex Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Addex Stock
0.67 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.61 | LLY | Eli Lilly | PairCorr |
0.7 | PFE | Pfizer Inc Aggressive Push | PairCorr |
Moving against Addex Stock
0.76 | GLABF | Gemina Laboratories | PairCorr |
0.65 | LFCR | Lifecore Biomedical | PairCorr |
0.62 | BMY | Bristol Myers Squibb | PairCorr |
0.46 | CTLT | Catalent | PairCorr |
0.45 | KMDA | Kamada | PairCorr |
The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.
The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Addex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Addex Therapeutics Correlation, Addex Therapeutics Volatility and Addex Therapeutics Alpha and Beta module to complement your research on Addex Therapeutics. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Addex Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.